The Seres 5 is a compact electric crossover from China, now available in Europe. With 577 hp, the top-spec model sprints from ...

Janney Montgomery Scott LLC decreased its stake in Seres Therapeutics, Inc. (NASDAQ:MCRB – Free Report) by 29.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...

Chinese carmaker Seres said on Tuesday that it delivered 17,906 NEVs in January, of which around 70 percent were its flagship AITO M9 SUVs. That means the model has maintained its position as the ...

Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upgrading its current co-marketing ...

A family is preparing for three fundraising challenges in memory of their husband and dad who received treatment at an Oxford ...

Matthew R. Henn, Chief Scientific Officer and Executive Vice President at Seres Therapeutics, Inc. (NASDAQ:MCRB), recently executed a series of stock transactions, according to a filing with the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ...

CAMBRIDGE, MA – Seres Therapeutics, Inc. (NASDAQ:MCRB), a biopharmaceutical company specializing in pharmaceutical preparations, announced on Monday the appointment of Dr. Hans-Juergen Woerle as ...

During the World Economic Forum's 2025 annual meeting held from January 20-24 in Davos-Klosters, Switzerland, nearly 3,000 representatives from 130 countries and regions discussed the theme ...